How Viibryd (Vilazodone) Works: The Science Behind This New Med
A clearer look at vilazodone's two serotonin actions, the evidence for depression and anxiety, and the practical details that matter when considering treatment.

In this article
Viibryd, the brand name for vilazodone, offers a different way of working with serotonin. I want to explain what makes it distinctive, what studies show, and why it may be worth discussing when another antidepressant has not been a good fit.12
What is Viibryd?
Vilazodone is an antidepressant approved in the United States for major depressive disorder in adults. Its first U.S. approval was in 2011.1
The useful question is how it might fit your treatment goals. A medicine does not need to be the newest or most widely prescribed option to deserve a thoughtful conversation.
How it works: two actions involving serotonin
Like an SSRI, vilazodone slows serotonin reuptake by inhibiting the transporter that recycles released serotonin into a nerve cell.1
It also partly activates the 5-HT1A serotonin receptor. A partial agonist stimulates a receptor less strongly than a full agonist; this adds receptor activity to its reuptake-blocking action.1
These complementary actions change serotonin signaling. They do not replace serotonin or guarantee a double benefit; researchers are still clarifying how much the receptor action contributes to antidepressant effects.1
What does the depression research show?
Controlled trials support vilazodone as a treatment for depression. One 10-week study included 1,133 adults and compared two vilazodone doses, citalopram, and placebo. Both vilazodone groups and the citalopram group improved more than placebo on the main depression measure.2
That is encouraging evidence of benefit. It does not establish that vilazodone is better than citalopram or other antidepressants. In that study, sustained-response rates were not significantly different from placebo, even though overall symptom scores improved more.2
For someone who has struggled with another treatment, the conversation can still be hopeful: does vilazodone offer a reasonable next option, given previous benefits, side effects, and priorities? The aim is a treatment that helps you function and feel better, with tolerability you can live with.
Could it also help anxiety?
There are positive findings in generalized anxiety disorder. In an eight-week randomized trial involving 400 adults in the efficacy analysis, vilazodone improved anxiety and functional-impairment scores more than placebo. More people receiving vilazodone stopped treatment before the study ended, and stomach-related side effects were among the common problems.3
These findings give clinicians a reason to consider its potential. Anxiety treatment remains an off-label U.S. use, meaning it is outside its FDA-approved indication. Discuss the anxiety symptoms you want to target and why this option might suit you.13
Taking it with food—and allowing time
Food matters: taking vilazodone on an empty stomach can substantially reduce absorption. The labeled target is 20–40 mg once daily with food, reached gradually from a lower starting dose. Follow your own prescription and switching plan.1
It may take several weeks to feel the full benefit. Arrange follow-up rather than deciding whether it works from the first few doses. Do not stop abruptly; a prescriber can help you taper to reduce withdrawal symptoms.4
Side effects and safety worth discussing
Nausea, diarrhea, vomiting, and insomnia were common adverse effects in the depression trial. Report symptoms that persist or disrupt daily life so your prescriber can help you decide what to do.2
Sexual side effects are possible, including erection or orgasm difficulties. The trial found no significant between-group difference on its sexual-function questionnaire, so I would not describe Viibryd as reliably free of these problems. Raise changes openly rather than assuming they are inevitable or untreatable.24
- Share your full medication and supplement list. MAO inhibitors require specific separation periods, and other serotonin-affecting products can increase interaction risks.4
- Discuss any history of mania or bipolar disorder, seizures, bleeding problems, pregnancy, or breastfeeding before treatment.14
- Seek urgent assessment for fever with confusion, marked agitation, or muscle stiffness. These can signal serotonin syndrome.4
- Report new suicidal thoughts or sharply worsening mood promptly, especially early in treatment or after dose changes. Antidepressants carry a warning about increased suicidal thoughts and behavior in young people; seek emergency help if you cannot stay safe.4
My perspective: another option to understand
I have not taken Viibryd myself. When I first discussed it, I also had limited experience seeing it prescribed in an inpatient setting, so I cannot offer a personal account of taking it.
What interests me is its combination of serotonin reuptake inhibition and receptor activity. It offers a distinct option without needing to be presented as a breakthrough for everyone.
If you are considering it, ask your prescriber: Why this medicine for me? What changes should we track? How will we handle side effects, and when will we review progress? A disappointing experience with one medication can be the start of a better-informed next step.
Words worth knowing
Insomnia
A sleep disorder involving persistent difficulty falling asleep, staying asleep, or getting restorative sleep.
References
- DailyMed — Viibryd prescribing information: approved use, mechanism, food effect, and dosing
- Mathews et al. (2015) — randomized trial of vilazodone, citalopram, and placebo in major depression
- Durgam et al. (2016) — randomized placebo-controlled trial in generalized anxiety disorder
- MedlinePlus — vilazodone: taking it, interactions, precautions, side effects, and withdrawal
